Esperion Therapeutics
ESPR
#8266
Rank
โ‚ฌ0.16 B
Marketcap
0,81ย โ‚ฌ
Share price
4.39%
Change (1 day)
-59.39%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of April 2025 (TTM): 0.5397

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.4614. At the end of 2024 the company had a P/S ratio of 1.35.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.35-53.75%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.36 1,078.61%๐Ÿ‡บ๐Ÿ‡ธ USA
4.23 684.71%๐Ÿ‡บ๐Ÿ‡ธ USA
2.04 278.47%๐Ÿ‡บ๐Ÿ‡ธ USA
4.59 750.71%๐Ÿ‡บ๐Ÿ‡ธ USA
4.27 690.43%๐Ÿ‡บ๐Ÿ‡ธ USA
8.39 1,453.70%๐Ÿ‡บ๐Ÿ‡ธ USA